THE TRADERS GUILD (WHALE)

[westwich]

MLGT: China SnapChat HQs now in SoftWare Park. China.

Great to see.
8-K 4/24/17:
On March 31, 2017, the Company moved its principle office to Room 1205, 1A Building, Shenzhen Software Industry Base, Xuefu Rd, Nanshan District, Shenzhen,Guangdong Province, China. The Company’s telephone and fax numbers also changed, phone: [phone], fax: [phone]

[PENNIEStoSTACKS]

Great services form the Company below, .0003's drop and .00's should come quickly.

[TradeSmart.ai]

Haha weeeeeeeeee x billion!!!

[BoilerRoom]

Weeeeeeeeeeer

[TradeSmart.ai]

Lmfao nice broski

[BoilerRoom]

Heck yea buddy it's my Friday off for 4 days...

[TradeSmart.ai]

Buahahah weeeeeee brother!!!! Hope you're having a good weekend man

[BoilerRoom]

Stop calling all these winners your about to pass me with people marks

[$Pistol Pete$]

$PMCB UNC-Led Cannabis Research Sees Significant Progress PMCB

Research led by University of Northern Colorado Professor Richard Hyslop is making significant progress in developing a targeted cancer treatment using cannabinoids as a chemotherapy agent, according to a news release issued Monday.

The UNC research has concentrated on the feasibility of developing cells capable of producing an enzyme that can convert inactive cannabis compounds into an active anti-cancer drug.

Hyslop, who's working on the project with PharmaCyte Biotech Inc., summarized the progress during presentations last week at the 253rd American Chemical Society National Meeting & Exposition in San Francisco.

Researchers to date have observed five cell lines that produce desired enzymes to convert inactive cannabis compounds into anti-cancer drugs once they're injected, using PharmaCyte's encapsulation technology, and then activated directly at the site of a tumor.

Hyslop has been involved in cancer research for four decades and is leading a team of scientists from UNC to develop a "green" approach to treating solid tumors, initially brain cancer.

http://www.unco.edu/news/releases.aspx?id=10787

[TradeSmart.ai]

My MJ Picks for tomorrow: Bullish charts on all 3 but here's why: $APRU Kannakick and LiveWire Energy chew products relaunch news with $MJNA and $LVVV supposedly more news to come this or next week, $NNSR to have their Cannacap/Cannapipe website to go live tomorrow and other MJ news for 4/20 and of course $OWCP put out the 8K today that the CEO was out and a new CEO is in. This guy has some good experience and brings a lot of knowledge to the table.

https://www.otcmarkets.com/edgar/GetFilingPdf?FilingID=12002747

https://kannaway.com/kannakick-is-back/

Also this:
$OWCP ANNUAL REPORT CLARIFICATION FOR SHAREHOLDERS:

1)
Page 5: Don't get confused by the OWCP already done Psoriasis study (where efficacy results are imminent) and next deeper and extended studies planned from April: "On February 1, 2017, following the very encouraging results that have been achieved at the mid-point of the Study, the Company determined to extend the size and scope of the Study for the purpose, among other things, of checking the biological markers that have been generated to date with respect to the treatment of psoriasis (proliferation/ inhibition and several interleukins). Despite extending its size and scope of the Study, the Registrant expects to compete the Study during the 2 nd or 3 rd quarters of 2017."
The study already done is confirmed in page 36:
"We have been conducting a study on the efficacy of the cannabinoid-based topical cream for the treatment of skin conditions generally and psoriasis specifically, which commenced in November, 2016 "
While the extended study to start in April 2017 according to previous 8K is the safety phase and identification of biological markers useful to identify potential other application of the cream (Skin Cancer imo):
"We started safety phase at the hospital by this month, April 2017, and already planning a unique multi-center efficacy study. This is the natural development of the next generation of safe and tested cannabinoids treatments"

2)
Page 5-6: Multiple Myeloma Amazing News for Shareholders is here:
"Dr. Leiba led our in vitro studies on the effect of a formulation comprised of Cannabidiol (CBD) and tetrahydrocannabinol (THC) on multiple myeloma cells studied outside their normal biological context. The results indicated a 100% mortality rate of myeloma cells in 80% of the cultured cells within a 24 to 48-hour period, and highlight the potential abilities of cannabis oil extract to fight multiple myeloma cancer cells. We believe that the results of this study indicate a potential to develop a more effective treatment for multiple myeloma than standard therapies."
"Expect to submit a clinical trial protocol to the Israeli Institutional Review Board and received its approval to commence a clinical study"
"Intend to commence a clinical study in the third quarter of 2017"

3)
Notes on competition page 7: For Psoriasis they aim to attack Big Pharma market and they are well aware of current products and thier limitation:
"The current common treatments for psoriasis include topical and systemic drugs, steroids, immunosuppressive drugs such as Cyclosporine A (by Novartis), methotrexate or MTX and biological drugs such as Enbrel (by Amgen), Amevive (by Biogen but whose patent expired in 2013) and Ustakinumabn (by Janssen Immunology)." This is excelent Marketing strategic approach;

4)
Page 8: Provisional Patents are listed in report, can be downloaded through reference number and are real! They are extremely well written in a professional way and full of interesting claims: when needed (close to deadline) they will pay the service fees and transform them in Official US Permanent Patent; Why to do it before if the provisional is free of charge? Smart approach;

5)
Page 12: CERTIFICATION and FDA approval all diligently work has been done according to standard: "
Israel’s Ministry of Health, which regulates medical testing, has adopted protocols that correspond, generally, to those of the FDA and the EMA, making it comparatively straightforward for studies conducted in Israel to satisfy FDA and the European Medicines Agency requirements, thereby enabling medical technologies subjected to clinical trials in Israel to reach U.S. and EU commercial markets in an expedited fashion. Many members of Israel’s medical community have earned international prestige in their chosen fields of expertise and routinely collaborate, teach and lecture at leading medical centers throughout the world. Israel also has free trade agreements with the United States and the European Union."

6)
Financial page 47: OWCP company costs are low, 2M$/year despite improvements on multiple studies e.g. Psoriasis efficacy results announced in previous 8K;

7) Annual report page 46: Dilution is not an issues, AS stable at 500M and OS~140M, OWCP is a LOW FLOAT: Confirmed Financing few Million dollars needed for 2017 will be just a sale of few millions shares, therefore FEW PERCENT OF CURRENT OS: NO or NEGLIGEBLE DILUTION;Financing for 2017 is therefore not an issue;

8)
Page 66: Subsequent Event: even in 2017 in the quarter not covered in the report and in the past two weeks (also when the price reached 3$) the Company didn't start dilution and sales of massive quantity of shares: ~1.7M$ sold to cover operation and expansion.

[TradeSmart.ai]

Weeeee haha thank you brother :)

[GrooveMaster]

LOL I saw the post and was thinking about my prior post on here....click on it and you are replying to it... LOL
$NWAV Epic run coming somewhere soon!!! The DD is deep!!

http://www.altmedcenters.com/

http://pao.group/

http://pao.group/store/

PAO Group, Inc. Anti-Opiate Crusade Charges on with Opening of Flagship Location in State of Ohio
http://ih.advfn.com/p.php?pid=nmona&article=74318199

PAO Group, Inc. Focusing on 2017 Growth Expansion Initiatives
http://ih.advfn.com/p.php?pid=nmona&article=72741925

NWAV ROADTRIP SUMMARY & REPORT
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=130328503

St Augustine, Florida Medical Clinic

Sandusky, Ohio Medical Clinic

Ft Lauderdale, Florida Medical Clinic

Parma, Ohio Medical Clinic

[TradeSmart.ai]

Yes is saw it watching it today lol

[GrooveMaster]

StockWhale have you seen the latest DD on NWAV?

NEWS Yesterday!!
http://ih.advfn.com/p.php?pid=nmona&article=74318199&symbol=NWAV

Drive by of all 4 open Clinics by an investor...
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=130361464

[TradeSmart.ai]

$OTTV brother this CEO Means business!!!

[The Night Stalker]

SVTE going mid term just needs fresh new money , might fine fins for a 000 and 348m O/S is a sleeper

[TradeSmart.ai]

Nice pop EOD

[The Night Stalker]

SVTE 348M OS you think you can run it?

[TradeSmart.ai]

Watching thank you!

[KEEMAJO]

MLGT: DOLV investors loading up before R/M news release>

Moderate volume on Monday & up roughly 40%.

The MLGT reverse merger news is yet to be posted and already the stock is starting to roll.

Imo, it is quite likely that the tiny MLGT float will lock sometime this week and cause a vertical move.

MLGT is now a China social media stock

MLGT is now run by three young Chinese Silicon Valley-type players that own 87% of ALL of the MLGT stock.

The other 13%, (roughly 24M shares), is almost all locked up.

MLGT stock action is about to get truly nuts.

LINK: Here is one of MLGTs China social media apps that is now live for download in China.
https://appadvice.com/game/app/e5-b0-8f-e6-81-8b-e7-88-b1-e5-90-8c-e5-9f-8e-e9-82-82-e9-80-85-e7-a4-be-e4-ba-a4app/1142497695

Also......
http://www.ixiaolianai.com/

[TradeSmart.ai]

Oh gotcha

[Mean Weimaraner]

I will add u only a few of us.. but no OPMZ just something I stumbled on recently L2 got me baited in

[TradeSmart.ai]

Month ago*

[TradeSmart.ai]

Hmmm interesting I know Sunny was in it a week or so ago.

[Mean Weimaraner]

Yes but only really one worth being in ;) just got into that actually

[TradeSmart.ai]

Wow think it might make another run? Btw are you in any of the chats on Twitter?

[Mean Weimaraner]

Unusual propping over at $OPMZ tweeted the screenshot cuz I'm on ihub mobile so can't post here..

Dudes'll back off if getting hit hard but they're actually filling.. worth a closer look imo 27mil bids @0053 at one point today... sheesh

[The Night Stalker]

AFTC 592m OS

https://www.otcmarkets.com/stock/AFTC/profile

[TradeSmart.ai]

They got multiple basher mods though

[The Night Stalker]

INOH gone current today

[The Night Stalker]

will like it in a bit

[TradeSmart.ai]

NEW FB PAGE

[X-ray07]

Cegx --- good call Mr. Millionzzz

[TradeSmart.ai]

True

[The Night Stalker]

OXIHF mercy post for me say you are in then it wakes up

The Liberal government will announce legislation next month that will legalize marijuana in Canada by July 1, 2018.

CBC News has learned that the legislation will be announced during the week of April 10 and will broadly follow the recommendation of a federally appointed task force that was chaired by former liberal Justice Minister Anne McLellan.

http://www.cbc.ca/beta/news/politics/liberal-legal-marijuana-pot-1.4041902

[TradeSmart.ai]

Lolzzzzz :P

[The Night Stalker]

get OXIHF going canadian MJ april 10 event

then i follow you like a hawk, ima stalk the shit out of you XD

[TradeSmart.ai]

lmfao nah not yet, getting there eventually :]

[The Night Stalker]

are you a millionaire yet sw?

[BoilerRoom]

$USRM ALL IN ONE DD Post for Investors:

Here is a compilation of DD that I have put together for new investors in USRM.

US. Stem Cell Inc. Youtube Channel
https://www.youtube.com/user/bioheartinc

US. Stem Cell Inc. Website
http://us-stemcell.com/en/home-2/

US. Stem Cell Inc. Facebook
https://www.facebook.com/USStemCellInc/

US. Stem Cell Clinic Website
http://usstemcellclinic.com/en/home/

Vetbiologics Website
http://www.vetbiologics.com

US. Stem Cell Training Website
https://www.usstemcelltraining.com

[$Pistol Pete$]

$PMCB Global Pancreatic Cancer Treatment Market Analysis, Share, Trends and Forecast by 2025 PMCB




http://www.medgadget.com/2017/03/global-pancreatic-cancer-treatment-market-analysis-share-trends-and-forecast-by-2025.html

[$Pistol Pete$]

$CFGX Life Insurance



Backed Lending
Value Proposition: We help insurance trusts and pension plans obtain needed liquidity based on the cash surrender value of their life insurance policies, annuity contracts, and other tangible assets.

Features: We offer credit facilities, premium finance arrangements, and other custom lending solutions to meet your needs. Typically, lending terms are 1 month LIBOR + Margin, interest only, over 5 years.

Benefits: With our services, plan administrators can invest previously inaccessible value and feel confident they will be able to meet their pension obligations and planned benefit payouts by unlocking the cash tied up in their plan and policy assets.

Action: If you are interested in obtaining these services please contact us for a consultation.

http://capfiglobal.com/services/prohibited. If you have received this message in error, please immediately notify the sender and delete or destroy any copy of this message.

[TradeSmart.ai]

Yes I've been watching it today what a move looking good for further continuation.

[SidewaysTrader]

Got me some of that MFST just a bit ago. Nobody is selling into the bid and VNDM is getting thin on shares now. It took 3 million shares to get him to move off of .0063 this morning and now it's only taking about 1 million to push it up each time.

[TradeSmart.ai]

$MMEX $MFST $SLIO killing it today wow

[BottomBounce]

$FDBL Newly Designed Site Highlights Multi-Product Platform

$FDBL Friendable, Inc. (the “Company”) , a mobile & social focused technology company, focused on connecting users with location-specific, interactive and live content, today announced the launch of its new website at www.Friendable.com. The refreshed look and new design match Friendable’s growing excitement for the future of what it believes is its game-changing mobile applications.

Friendable’s new site was designed with the Company’s users and investors in mind. It features a complete resource center that details Friendable’s products and video assets and streamlined navigation. The new site also has a detailed Investor Relations section with key Company metrics and full investor presentation available for download. Friendable has also provided a sneak peek video of its latest mobile app, “Fan Pass,” currently in its internal beta release stage. A link to this video can be found by clicking on the “Fan Pass” logo directly from the Company’s website.

Robert A. Rositano Jr., Friendable, Inc. CEO, stated, “Friendable has worked hard to expand its product offerings to include two formidable mobile applications that have the potential to drive substantial growth and shareholder value. The launch of our redesigned website gives our users and investors the tools they need to understand and analyze our Company and its two products. We invite visitors to explore our new site and achieve a better understanding of the full breadth of our Company’s capabilities. Our new site sets the tone for a communications strategy that will always look to keep the marketplace current on the latest Company developments by sharing useful updates on our exciting platforms for growth.”

About Friendable Friendable Inc. is a mobile technology company that develops, acquires, and invests in mobile applications with a social focus. In 2013, the Company released its flagship product Friendable, a mobile social application where users can create one-on-one or group-style meetups for food, drinks, live music, or any occasion. In 2017, Friendable Inc. will release its brand new mobile app platform “Fan Pass Live”, a live streaming video application for both iPhone and Android, platform designed to allow music artists, athletes and celebrities to offer their fans and social followers a backstage or VIP experience right from their smart phone. Through the Friendable and Fan Pass applications, Friendable Inc. aims to become the premier brand, for mobile platforms that are dedicated to connecting and engaging users beyond today’s limitations.

Visit our social media properties Facebook: http://facebook.com/friendable
Twitter: https://twitter.com/friendableapp
Instagram: https://www.instagram.com/friendableapp/

http://emerginggrowth.com/friendable-inc-otc-pink-fdbl-just-got-whole-lot-better/

[BottomBounce]

$ASTI 2nd Resistance Point 0.0048
1st Resistance Point 0.0033
Last Price 0.002

[Mean Weimaraner]

$BMBM .019 r/m barchart 88% buy

[KEEMAJO]

New it. Wish I followed you on GIGL. Not going to miss ENDV too. Thanx

[TradeSmart.ai]

Lol still there